[1] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 肝脏, 2015, 20:750-767.
[2] Lee W M. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol, 2012, 26:3-16.
[3] Onakpoya I J, Heneghan C J, Aronson J K. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med, 2016, 14:10.
[4] Masyuk A I, Masyuk T V, Larusso N F. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol, 2013, 59:621-625.
[5] Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol, 2013, 200:373-383.
[6] Keller S, Sanderson M P, Stoeck A, et al. Exosomes: from biogenesis and secretion to biological function. Immunol Lett, 2006, 107:102-108.
[7] Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology, 2012, 56:1946-1957.
[8] Cho Y E, Kim S H, Lee B H, et al. Circulating plasma and exosomal microRNAs as indicators of drug-induced organ injury in rodent models. Biomol Ther (Seoul), 2017, 25:367-373.
[9] Xie J X, Fan X, Drummond C A, et al. MicroRNA profiling in kidney disease: Plasma versus plasma-derived exosomes. Gene, 2017, 627:1-8.
[10] Motawi T K, Mohamed M R, Shahin N N, et al. Time-course expression profile and diagnostic potential of a miRNA panel in exosomes and total serum in acute liver injury. Int J Biochem Cell Biol, 2018, 100:11-21.
[11] Koberle V, Pleli T, Schmithals C, et al. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One, 2013, 8:e75184.
[12] Zheng J, Yu L, Chen W, et al. Circulating exosomal microRNAs reveal the mechanism of Fructus Meliae Toosendan-induced liver injury in mice. Sci Rep, 2018, 8:2832.
[13] Kalra H, Simpson R J, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol, 2012, 10:e1001450.
[14] Palomo L, Mleczko J E, Azkargorta M, et al. Abundance of cytochromes in hepatic extracellular vesicles is altered by drugs related with drug-induced liver injury. Hepatol Commun, 2018, 2:1064-1079.
[15] Rodriguez-Suarez E, Gonzalez E, Hughes C, et al. Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity. J Proteomics, 2014, 103:227-240.
[16] Alvarez M L, Khosroheidari M, Kanchi Ravi R, et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney International, 2012, 82:1024-1032.
[17] Yang X, Greenhaw J, Shi Q, et al. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol Sci, 2012, 125:335-344.
[18] Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, et al. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl, 2010, 4:416-425.
[19] Camussi G, Deregibus M C, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans, 2013, 41:283-287.
[20] Jiang W, Tan Y, Cai M, et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect. Stem Cells Int, 2018, 2018:6079642.
[21] Tan C Y, Lai R C, Wong W, et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther, 2014, 5:76.
[22] Nojima H, Freeman C M, Schuster R M, et al. Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. J Hepatol, 2016, 64:60-68.
[23] Cho Y E, Seo W, Kim D K, et al. Exogenous exosomes from mice with acetaminophen-induced liver injury promote toxicity in the recipient hepatocytes and mice. Sci Rep, 2018, 8:16070.
[24] Royo F, Palomo L, Mleczko J, et al. Metabolically active extracellular vesicles released from hepatocytes under drug-induced liver-damaging conditions modify serum metabolome and might affect different pathophysiological processes. Eur J Pharm Sci, 2017, 98:51-57. |
